How effective are prescriptive governance tools? Results from the application of AIFA notes
DOI:
https://doi.org/10.33393/grhta.2024.3027Keywords:
AIFA notes, Appropriateness, Phamaceutical governance, Real-world evidenceAbstract
Introduction: Prescription appropriateness is crucial for healthcare, balancing scientific evidence, optimal benefit/risk ratios and cost-effectiveness in alignment with the National Health System (NHS) sustainability. In Italy, various governance tools, including Notes AIFA, regulate drug reimbursements. This research aims to evaluate the impact of the introduction of Notes AIFA in curbing consumption and expenditures and assessing their lasting effects. We evaluate the effect generated by the Notes in terms of prescriptive appropriateness by assessing their effect on reducing overprescribing phenomena for drugs covered by the Notes. Note 96, focused on the prevention and treatment of vitamin D deficiency in adults, is used as a case study to evaluate the short- and long-term effectiveness of these tools on prescribing behaviors.
Methods: Using a quasi-experimental approach, administrative data on pharmaceutical consumption in Tuscany over 60 months (22 pre- and 38 post-Note) were analyzed. Interrupted Time Series (ITS) analysis at regional, and local health authorities (LHAs), and primary care group practices (AFTs) was performed.
Results and conclusions: The ITS analysis showed an immediate reduction in consumption rates and spending post-Note 96. This real-world study highlights short-term effectiveness and suggests a positive long-term impact, despite recognizing a physiological increase in consumption at the regional level. The findings emphasize that ongoing continual monitoring of its effectiveness is imperative to promptly identify failures in implementation and mitigate the risk of consumption escalation, potentially reverting to pre-intervention levels.
Downloads
References
Agenzia Italiana del Farmaco (AIFA). Note AIFA | [Internet]. (Accessed September 2023) Online: https://www.aifa.gov.it/note-aifa
Addis A, Martini N. Dalle note limitative ai registri AIFA. Recenti Prog Med 2013;104(6):229-235. Online Dalle note limitative ai registri AIFA — Innovazione sanitaria e sociale (regione.emilia-romagna.it)
Panteli D, Arickx F, Cleemput I, et al. Pharmaceutical regulation in 15 European countries review. Health Syst Transit. 2016 Oct;18(5):1-122. PMID: 27929376.
Nuti S. La valutazione della performance in sanità. Il Mulino; 2008. 1–772 p.
Vainieri M, Vola F, Ferrè F, Orio G. D’, Cerasuolo D, Nuti S. Il sistema di valutazione della performance dei sistemi sanitari regionali, Report 2021 [Internet]. 2022 (Accessed October 2023). Online https://www.iris.sssup.it/handle/11382/554212
Vola F, Benedetto V, Vainieri M, Nuti S. The Italian interregional performance evaluation system. Research in Health Services & Regions. 2022;1(1):10. (Accessed October 2023). doi:10.1007/s43999-022-00010-6 DOI: https://doi.org/10.1007/s43999-022-00010-6
Armeni P, Jommi C, Otto M. The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: italy as a case study. Eur J Health Econ. 2016;17(8):963-977. doi:10.1007/s10198-015-0739-0 DOI: https://doi.org/10.1007/s10198-015-0739-0
Trotta F, Guerrizio MA, Di Filippo A, Cangini A. Financial Outcomes of Managed Entry Agreements for Pharmaceuticals in Italy. JAMA Health Forum. 2023;4(12):e234611. doi:10.1001/jamahealthforum.2023.4611 DOI: https://doi.org/10.1001/jamahealthforum.2023.4611
Willmington C, Vainieri M, Seghieri C. Estimating variations in the use of antibiotics in primary care: insights from the Tuscany region, Italy. Int J Health Plann Manage. 2022;37(2):1049-1060. doi:10.1002/hpm.3388 DOI: https://doi.org/10.1002/hpm.3388
Guidotti E, Vinci B, Attanasio F, Vola F. Effective tools to manage biosimilars prescription: the Italian experience. Health Policy Technol. 2021;10(1):45-51. https://doi.org/10.1016/j.hlpt.2020.10.011 DOI: https://doi.org/10.1016/j.hlpt.2020.10.011
Moretti G, Vinci B, Zito S, Caputo A, Attanasio F, Vainieri M. Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region. PLoS One. 2023 Sep 14;18(9):e0291628. https://doi.org/10.1371/journal.pone.0291628 PMID:37708187 DOI: https://doi.org/10.1371/journal.pone.0291628
Agenzia Italiana del Farmaco (AIFA). L’uso dei farmaci in Italia. Rapporto OsMed 2019 (Accessed September 2023). Online https://www.aifa.gov.it/-/l-uso-dei-farmaci-in-italia-rapporto-osmed-2019
Hudson J, Fielding S, Ramsay CR. Methodology and reporting characteristics of studies using interrupted time series design in healthcare. BMC Med Res Methodol. 2019;19(1):137. Accessed September 19, 2023 doi:10.1186/s12874-019-0777-x PMID:31272382 DOI: https://doi.org/10.1186/s12874-019-0777-x
Giulio de Belvis A, Meregaglia M, Morsella A, Adduci A, Perilli A, Cascini F, Solipaca A, Fattore G, Ricciardi W, Maresso A, Scarpetti G. Italy: Health System Review. Health Syst Transit. 2022 Dec;24(4):1-236. PMID: 36951263
Ministero di Economia e Finanza. Dipartimento delle finanze. Decreto-Legge del 30/09/ 2003 n. 269. Disposizioni urgenti per favorire lo sviluppo e per la correzione dell’andamento dei conti pubblici. Articolo 48. Online Documentazione Economica e Finanziaria - Dettaglio Articolo (finanze.it)
Sara Barsanti & Manila Bonciani & Federico Vola & Luca Pirisi, 2016. "Innovatori, indecisi, bisognosi o autonomi. I medici di medicina generale tra integrazione e accountability, MECOSAN, FrancoAngeli Editore, 2016(98):9-39. https://doi.org/10.3280/MESA2016-098002 DOI: https://doi.org/10.3280/MESA2016-098002
Barsanti S, Vola F, Bonciani M. Trade union or trait d'union? Setting targets for general practitioners: A regional case study. Int J Health Plann Manage. 2020 Jan;35(1):262-279. https://doi.org/10.1002/hpm.2903 PMID: 31670417. DOI: https://doi.org/10.1002/hpm.2903
Regione Toscana. Delibera n.1319 del 27-11-2017-Allegato-A. Nov 27, 2017. Online http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiG.xml?codprat=2017DG00000001489 (Accessed January 2024)
Regione Toscana. Delibera n.853 del 10-10-2011 - Allegato A. 2011. Online (http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiG.xml?codprat=2011DG00000001300 ) (Accessed January 2024)
Regione Toscana. Delibera n. 828 del 23-07-2018. 2018. Online (http://www301.regione.toscana.it/bancadati/atti/DettaglioAttiG.xml?codprat=2018DG00000000991 ) (Accessed January 2024)
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017 Feb 1;46(1):348-355. https://doi.org/10.1093/ije/dyw098 PMID_27283160 DOI: https://doi.org/10.1093/ije/dyw098
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Global & Regional Health Technology Assessment agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Accepted 2024-04-30
Published 2024-06-10